New smartphone eye test could bring vision checks to your home
NCT ID NCT06908967
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new smartphone-based device called EyeMirage that uses artificial intelligence to perform eye exams remotely. Researchers compared its results to standard clinic equipment in 160 adults aged 18 to 65. The goal was to see if the device could accurately measure vision, color vision, visual field, and eye movement, potentially allowing people to get eye exams without visiting a clinic.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- EyeMirage device (smartphone-based AI eye exam tool)
- What this could lead to
- If successful, this could enable reliable remote eye exams, making vision testing more accessible for people who cannot easily visit a clinic.
- What could go wrong
- This is a small, completed study comparing a new device to standard care. The results may not apply to all eye conditions or settings, and the device may not be as accurate as traditional methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
160 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Evidence of a signed and dated informed consent document confirming that the participant has been informed of all aspects of the clinical study. * Male or female participants, 18 to 65 years of age at time of screening. * Visual acuity of 20/200 or better. * Willingness to comply with required screening procedures, eye assessments, and follow-up visits, if needed. Exclusion Criteria: * Visual acuity worse than 20/200 in either eye * Complete blindness or diffuse vision loss in either eye * Clinical diagnosis of cognitive and motor diseases including but not limited to the following: 1. Neurodegenerative diseases such as dementia-like Alzheimer's disease, posterior cortical atrophy 2. Movement disorders such as Parkinson's disease and Parkinsonism tremors 3. Multiple sclerosis, stroke or any other neurological or physical conditions with paresis or plegia (i.e. weakness or paralysis of the limbs) * Eyes with a spherical equivalent of greater than +9 or -9 diopters where the corrective lens is too large to fit in the headset.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Visual function are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Armstrong + Small Eye Care Centre
Winnipeg, Manitoba, R3G 0S7, Canada
-
Brain, Vision and Concussion Clinic
Winnipeg, Manitoba, R2M 2X9, Canada
-
Prairie Eye Care (Northgate)
Winnipeg, Manitoba, R2V 3C4, Canada
-
St. Boniface Eye Care Centre
Winnipeg, Manitoba, R2H 0S8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.